- Home
- CMS vs BNTX Comparison
CMS vs BNTX Comparison
Compare CMS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMS | BNTX |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CMS | BNTX |
|---|---|---|
| Price | $70.36 | $96.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $78.83 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 02-05-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.47 | N/A |
| Revenue | ★ $8,295,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $8.76 | $2.03 |
| Revenue Next Year | $3.99 | N/A |
| P/E Ratio | $20.15 | ★ N/A |
| Revenue Growth | ★ 10.96 | 3.70 |
| 52 Week Low | $63.97 | $81.20 |
| 52 Week High | $76.45 | $129.27 |
Technical Indicators
Market Signals| Indicator | CMS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 51.70 |
| Support Level | $69.72 | $94.00 |
| Resistance Level | $70.70 | $95.71 |
| Average True Range (ATR) | 0.80 | 1.72 |
| MACD | 0.14 | 0.62 |
| Stochastic Oscillator | 73.46 | 81.33 |
Price Performance
Historical ComparisonAbout CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.